Medicenna Therapeutics to join two investor conferences in February 2025
financialpost.com — February 5, 2025, 01:01 PM UTC
Medicenna Therapeutics will participate in two investor conferences in February 2025. The events will include a presentation on February 11 and a fireside chat on February 28 in New York City. The company will also hold one-on-one meetings with investors during these conferences. Medicenna focuses on developing Superkines for cancer and autoimmune diseases, with ongoing clinical trials for its therapies.